276 related articles for article (PubMed ID: 21296866)
1. The zebrafish dag1 mutant: a novel genetic model for dystroglycanopathies.
Gupta V; Kawahara G; Gundry SR; Chen AT; Lencer WI; Zhou Y; Zon LI; Kunkel LM; Beggs AH
Hum Mol Genet; 2011 May; 20(9):1712-25. PubMed ID: 21296866
[TBL] [Abstract][Full Text] [Related]
2. Developmental defects in a zebrafish model for muscular dystrophies associated with the loss of fukutin-related protein (FKRP).
Thornhill P; Bassett D; Lochmüller H; Bushby K; Straub V
Brain; 2008 Jun; 131(Pt 6):1551-61. PubMed ID: 18477595
[TBL] [Abstract][Full Text] [Related]
3. Zebrafish models for human FKRP muscular dystrophies.
Kawahara G; Guyon JR; Nakamura Y; Kunkel LM
Hum Mol Genet; 2010 Feb; 19(4):623-33. PubMed ID: 19955119
[TBL] [Abstract][Full Text] [Related]
4. A splice site mutation in laminin-α2 results in a severe muscular dystrophy and growth abnormalities in zebrafish.
Gupta VA; Kawahara G; Myers JA; Chen AT; Hall TE; Manzini MC; Currie PD; Zhou Y; Zon LI; Kunkel LM; Beggs AH
PLoS One; 2012; 7(8):e43794. PubMed ID: 22952766
[TBL] [Abstract][Full Text] [Related]
5. Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan.
Stevens E; Carss KJ; Cirak S; Foley AR; Torelli S; Willer T; Tambunan DE; Yau S; Brodd L; Sewry CA; Feng L; Haliloglu G; Orhan D; Dobyns WB; Enns GM; Manning M; Krause A; Salih MA; Walsh CA; Hurles M; Campbell KP; Manzini MC; ; Stemple D; Lin YY; Muntoni F
Am J Hum Genet; 2013 Mar; 92(3):354-65. PubMed ID: 23453667
[TBL] [Abstract][Full Text] [Related]
6. Insights from molecular dynamics simulations: structural basis for the V567D mutation-induced instability of zebrafish alpha-dystroglycan and comparison with the murine model.
Pirolli D; Sciandra F; Bozzi M; Giardina B; Brancaccio A; De Rosa MC
PLoS One; 2014; 9(7):e103866. PubMed ID: 25078606
[TBL] [Abstract][Full Text] [Related]
7. Muscular dystrophies due to glycosylation defects: diagnosis and therapeutic strategies.
Muntoni F; Torelli S; Wells DJ; Brown SC
Curr Opin Neurol; 2011 Oct; 24(5):437-42. PubMed ID: 21825985
[TBL] [Abstract][Full Text] [Related]
8. NAD+ improves neuromuscular development in a zebrafish model of FKRP-associated dystroglycanopathy.
Bailey EC; Alrowaished SS; Kilroy EA; Crooks ES; Drinkert DM; Karunasiri CM; Belanger JJ; Khalil A; Kelley JB; Henry CA
Skelet Muscle; 2019 Aug; 9(1):21. PubMed ID: 31391079
[TBL] [Abstract][Full Text] [Related]
9. A molecular overview of the primary dystroglycanopathies.
Brancaccio A
J Cell Mol Med; 2019 May; 23(5):3058-3062. PubMed ID: 30838779
[TBL] [Abstract][Full Text] [Related]
10. NAD+ biosynthesis ameliorates a zebrafish model of muscular dystrophy.
Goody MF; Kelly MW; Reynolds CJ; Khalil A; Crawford BD; Henry CA
PLoS Biol; 2012; 10(10):e1001409. PubMed ID: 23109907
[TBL] [Abstract][Full Text] [Related]
11. Whole exome sequencing identified a novel DAG1 mutation in a patient with rare, mild and late age of onset muscular dystrophy-dystroglycanopathy.
Dai Y; Liang S; Dong X; Zhao Y; Ren H; Guan Y; Yin H; Li C; Chen L; Cui L; Banerjee S
J Cell Mol Med; 2019 Feb; 23(2):811-818. PubMed ID: 30450679
[TBL] [Abstract][Full Text] [Related]
12. Mouse fukutin deletion impairs dystroglycan processing and recapitulates muscular dystrophy.
Beedle AM; Turner AJ; Saito Y; Lueck JD; Foltz SJ; Fortunato MJ; Nienaber PM; Campbell KP
J Clin Invest; 2012 Sep; 122(9):3330-42. PubMed ID: 22922256
[TBL] [Abstract][Full Text] [Related]
13. Aberrant glycosylation of alpha-dystroglycan and congenital muscular dystrophies.
Endo T
Acta Myol; 2005 Oct; 24(2):64-9. PubMed ID: 16550917
[TBL] [Abstract][Full Text] [Related]
14. Zebrafish Fukutin family proteins link the unfolded protein response with dystroglycanopathies.
Lin YY; White RJ; Torelli S; Cirak S; Muntoni F; Stemple DL
Hum Mol Genet; 2011 May; 20(9):1763-75. PubMed ID: 21317159
[TBL] [Abstract][Full Text] [Related]
15. Genes required for functional glycosylation of dystroglycan are conserved in zebrafish.
Moore CJ; Goh HT; Hewitt JE
Genomics; 2008 Sep; 92(3):159-67. PubMed ID: 18632251
[TBL] [Abstract][Full Text] [Related]
16. DAG1 mutations associated with asymptomatic hyperCKemia and hypoglycosylation of α-dystroglycan.
Dong M; Noguchi S; Endo Y; Hayashi YK; Yoshida S; Nonaka I; Nishino I
Neurology; 2015 Jan; 84(3):273-9. PubMed ID: 25503980
[TBL] [Abstract][Full Text] [Related]
17. biAb Mediated Restoration of the Linkage between Dystroglycan and Laminin-211 as a Therapeutic Approach for α-Dystroglycanopathies.
Gumlaw N; Sevigny LM; Zhao H; Luo Z; Bangari DS; Masterjohn E; Chen Y; McDonald B; Magnay M; Travaline T; Yoshida-Moriguchi T; Fan W; Reczek D; Stefano JE; Qiu H; Beil C; Lange C; Rao E; Lukason M; Barry E; Brondyk WH; Zhu Y; Cheng SH
Mol Ther; 2020 Feb; 28(2):664-676. PubMed ID: 31843448
[TBL] [Abstract][Full Text] [Related]
18. Profiling of the muscle-specific dystroglycan interactome reveals the role of Hippo signaling in muscular dystrophy and age-dependent muscle atrophy.
Yatsenko AS; Kucherenko MM; Xie Y; Aweida D; Urlaub H; Scheibe RJ; Cohen S; Shcherbata HR
BMC Med; 2020 Jan; 18(1):8. PubMed ID: 31959160
[TBL] [Abstract][Full Text] [Related]
19. Homozygous dystroglycan mutation associated with a novel muscle-eye-brain disease-like phenotype with multicystic leucodystrophy.
Geis T; Marquard K; Rödl T; Reihle C; Schirmer S; von Kalle T; Bornemann A; Hehr U; Blankenburg M
Neurogenetics; 2013 Nov; 14(3-4):205-13. PubMed ID: 24052401
[TBL] [Abstract][Full Text] [Related]
20. Genetic Engineering of Dystroglycan in Animal Models of Muscular Dystrophy.
Sciandra F; Bigotti MG; Giardina B; Bozzi M; Brancaccio A
Biomed Res Int; 2015; 2015():635792. PubMed ID: 26380289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
